BMO Capital initiated coverage of Axis Capital (AXS) with a Market Perform rating and $93 price target Axis was a top-performing insurance stock in 2024 and there is room for re-rating from a “still material valuation gap” between a revamped Axis versus its specialty-focused peers, as well as potential upside from promising expense initiatives, the analyst tells investors in a research note. However, BMO’s caution on the direction of pricing and its ability to sustain growth/its improved loss ratio tempers its bullishness for the shares.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXS:
- Axis Capital price target raised to $110 from $108 at Keefe Bruyette
- Axis Capital Aligns Strategy with Enstar Agreement
- Axis Capital, Enstar Group enter loss portfolio transfer reinsurance agreement
- Axis Capital price target raised to $110 from $90 at Roth MKM
- Axis Capital upgraded to Equal Weight from Underweight at Wells Fargo